Gene Therapy Template Will Help Streamline Review Of IND Submissions
This article was originally published in The Pink Sheet Daily
Executive Summary
CBER chemistry, manufacturing and control template is designed to assist FDA in the review of gene therapy INDs, a draft guidance states. The document will also help sponsors develop an adequate application.